These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12432324)

  • 1. Valacyclovir (valtrex) for herpes labialis.
    Med Lett Drugs Ther; 2002 Nov; 44(1143):95-6. PubMed ID: 12432324
    [No Abstract]   [Full Text] [Related]  

  • 2. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
    Baker D; Eisen D
    Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic suppressive therapy in recurrent herpes labia with valacyclovir in adolescents. Our experience].
    Ruiz-Villaverde R; Sánchez-Cano D
    An Pediatr (Barc); 2009 Nov; 71(5):473-4. PubMed ID: 19783490
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasculitic mononeuritis multiplex induced by valacyclovir.
    Pary LF; Henszel A; Kelkar P
    Neurology; 2004 May; 62(10):1906-7. PubMed ID: 15159513
    [No Abstract]   [Full Text] [Related]  

  • 6. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.
    Gilbert SC
    J Drugs Dermatol; 2007 Apr; 6(4):400-5. PubMed ID: 17668537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes virus-associated erythema multiforme following valacyclovir and systemic corticosteroid treatment.
    Inoue K; Kano Y; Kagawa H; Hirahara K; Shiohara T
    Eur J Dermatol; 2009; 19(4):386-7. PubMed ID: 19482587
    [No Abstract]   [Full Text] [Related]  

  • 9. [How contagious is herpes?].
    Färber I
    Med Monatsschr Pharm; 2005 Jan; 28(1):30. PubMed ID: 15693601
    [No Abstract]   [Full Text] [Related]  

  • 10. Herpes labialis.
    Worrall G
    Clin Evid; 2005 Dec; (14):2050-7. PubMed ID: 16620481
    [No Abstract]   [Full Text] [Related]  

  • 11. First one-day, oral antiviral for cold sores is approved.
    Dent Assist; 2003; 72(6):45. PubMed ID: 14705406
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral antivirals for the acute treatment of recurrent herpes labialis.
    Jensen LA; Hoehns JD; Squires CL
    Ann Pharmacother; 2004 Apr; 38(4):705-9. PubMed ID: 14966254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.
    Spruance SL; Jones TM; Blatter MM; Vargas-Cortes M; Barber J; Hill J; Goldstein D; Schultz M
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1072-80. PubMed ID: 12604544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of antiviral therapy for episodic treatment of herpes labialis: exploratory analyses of the combined data from two valaciclovir trials.
    Spruance SL; Hill J
    J Antimicrob Chemother; 2004 May; 53(5):703-7. PubMed ID: 15044423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valacyclovir HCl (Valtrex): an acyclovir prodrug with improved pharmacokinetics and better efficacy for treatment of zoster.
    Smiley ML; Murray A; de Miranda P
    Adv Exp Med Biol; 1996; 394():33-9. PubMed ID: 8815698
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic options for herpes labialis, I: Oral agents.
    Elish D; Singh F; Weinberg JM
    Cutis; 2004 Jul; 74(1):31-4. PubMed ID: 15293697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis.
    Amber KT; Castaño JE; Angeli SI
    Am J Otolaryngol; 2012; 33(4):487-8. PubMed ID: 22154065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contempo 1997: dermatology.
    Marks L; Saltzman R
    JAMA; 1997 Oct; 278(14):1148; author reply 1149. PubMed ID: 9326466
    [No Abstract]   [Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema caused by valacyclovir.
    Daito J; Hanada K; Katoh N; Katoh S; Sakamoto K; Asai J; Takenaka H; Kishimoto S
    Dermatology; 2009; 218(1):60-2. PubMed ID: 18974630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.